Federal Ministry of Health Appoints Doyin Bademosi As Member National Cancer Control Technical Working Group

The Federal Ministry of Health has appointed health technology expert Doyin Bademosi as a member of the Technical Working Group (TWG) for Nigeria’s National Cancer Control Plan (NCCP), signaling a renewed push toward digital innovation in the country’s fight against cancer.

Bademosi, who is the Founder and Chief Executive Officer of Durotimi AI, will serve as Chairman of the Cancer Data, Artificial Intelligence, and Digital Health Subcommittee. In this role, he is expected to provide strategic advisory support on advancing cancer surveillance systems, improving early detection protocols, and integrating artificial intelligence into Nigeria’s oncology framework.

The NCCP serves as Nigeria’s strategic roadmap for addressing the growing cancer burden and improving patient outcomes nationwide.

Health authorities say Bademosi’s appointment reflects a deliberate shift toward data-driven and technology-enabled healthcare solutions tailored to the country’s unique infrastructure and demographic needs.

Speaking on his appointment, Bademosi emphasized the importance of localized innovation in healthcare delivery.

“To move the needle on cancer survival in Nigeria, we must move beyond generic technology and embrace localized intelligence,” he said. “My mission has always been to ensure that AI acts as a clinical accelerator, not a barrier. I am honored to support the Ministry in building a sustainable, digitally enabled oncology framework that prioritizes early detection and equitable access for every Nigerian.”

According to officials, his work within the TWG will focus on developing interoperable and ethically sound digital health systems optimized for local populations, ensuring accessibility across diverse regions.

The Ministry noted that the inclusion of private-sector expertise in the NCCP underscores its commitment to public-private collaboration in tackling complex health challenges.

Bademosi brings over a decade of experience in health technology architecture, having led the design and deployment of innovative clinical solutions. Beyond his role at Durotimi AI, which operates from Minnesota in the United States with a European base in Ireland, he is also the founder of Radmol AI and a member of the Mayo Clinic Platform Accelerate alumni network.